Showing results (881-890 of 1,504) with videos related to
Sort By:
Pageof 151
The Lancet. Global Health|May 18, 2019
Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluationAnil Pooran, Grant Theron, Lynn Zijenah, et al.The Lancet. Global Health|March 18, 2022
Social and health factors associated with adverse treatment outcomes among people with multidrug-resistant tuberculosis in Sierra Leone: a national, retrospective cohort studyRashidatu Fouad Kamara, Matthew J Saunders, Foday Sahr, et al.The Lancet. Global Health|January 22, 2021
Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysisColin Gilmartin, Justice Nonvignon, Matthew Cairns, et al.The Lancet. Global Health|January 30, 2021
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurveyManoj V Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.The Lancet. Global Health|September 21, 2019
Cost-effectiveness and budget impact of the community-based management of hypertension in Nepal study (COBIN): a retrospective analysisAnirudh Krishnan, Eric Andrew Finkelstein, Per Kallestrup, et al.The Lancet. Global Health|September 21, 2019
Rheumatic heart disease burden, trends, and inequalities in the Americas, 1990-2017: a population-based studyPedro Ordunez, Ramon Martinez, Patricia Soliz, et al.The Lancet. Global Health|February 25, 2019
Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysisAllison Portnoy, Mark Jit, Matthew Ferrari, et al.The Lancet. Global Health|March 2, 2019
Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosisJean Jacques Noubiap, Jobert Richie Nansseu, Ulrich Flore Nyaga, et al.The Lancet. Global Health|August 13, 2019
Antibiotic prophylaxis in the surgical management of miscarriage in low-income countries: a cost-effectiveness analysis of the AIMS trialIlias Goranitis, David M Lissauer, Arri Coomarasamy, et al.The Lancet. Global Health|August 1, 2019
Effect of voluntary licences for hepatitis C medicines on access to treatment: a difference-in-differences analysisBryony Simmons, Graham S Cooke, Marisa MiraldoPageof 151